Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jul;95(7):1549-60.
doi: 10.1002/jps.20636.

Stability Profiles of Drug Products Extended Beyond Labeled Expiration Dates

Affiliations

Stability Profiles of Drug Products Extended Beyond Labeled Expiration Dates

Robbe C Lyon et al. J Pharm Sci. .

Abstract

The American Medical Association has questioned whether expiration dating markedly underestimates the actual shelf life of drug products. Results from the shelf life extension program (SLEP) have been evaluated to provide extensive data to address this issue. The SLEP has been administered by the Food and Drug Administration for the United States Department of Defense (DOD) for 20 years. This program probably contains the most extensive source of pharmaceutical stability data extant. This report summarizes extended stability profiles for 122 different drug products (3,005 different lots). The drug products were categorized into five groups based on incidence of initial extension failures and termination failures (extended lot eventually failed upon re-testing). Based on testing and stability assessment, 88% of the lots were extended at least 1 year beyond their original expiration date for an average extension of 66 months, but the additional stability period was highly variable. The SLEP data supports the assertion that many drug products, if properly stored, can be extended past the expiration date. Due to the lot-to-lot variability, the stability and quality of extended drug products can only be assured by periodic testing and systematic evaluation of each lot.

Comment in

Similar articles

See all similar articles

Cited by 7 articles

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback